Medical device company DexCom (NASDAQ:DXCM) will be reporting results tomorrow after market hours. Here’s what to look for.

But drugmakers are already bracing for those pharmaceutical-specific levies as they grapple with evolving trade policy, with ...

Wednesday closed up +0.15%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.35%, and the Nasdaq 100 Index ($IUXX) ...

This earnings season so far has reflected a continued recovery in sales for companies within the Medical sector. Earnings ...

The partnership extends the compatibility of Sequel’s Twiist system to allow people with Type 1 diabetes to pair the device ...

A review of S&P 500 companies’ 10-K reports reveals that references to diversity, equity and inclusion have fallen sharply ...

The global biosensors market is on an impressive growth trajectory, with its valuation expected to reach USD 31.8 billion in 2025 and soar to USD 76.2 billion by 2035, expanding at a Compound Annual ...

Rep. Robert Bresnahan, Jr. of Pennsylvania recently sold between $1,001 and $15,000 in Alphabet stock through his JP Morgan ...

Auctioneers Keane Mahony Smith, acting for Galway County Council, expects enquiries from public bodies, institutional ...

Representative Robert Bresnahan, Jr. sold shares of Eli Lilly and Company in April 2025, disclosing the transaction of $1,001 ...